News
Annovis achieves comprehensive intellectual property (IP) protection now covering both the original semi-crystalline and new ...
Despite firming US sales of its Rett syndrome treatment Daybue, Neuren Pharmaceuticals (ASX:NEU) says two-thirds of eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback